Histological Analysis of CelluJuve® Injections in the Brachium

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 28, 2025

Primary Completion Date

July 15, 2025

Study Completion Date

April 15, 2027

Conditions

Healthy Male and Female Subjects

Interventions

DEVICE

CelluJuve®

CelluJuve® injected into upper brachium

Trial Locations (1)

BioPharma Services Inc., North York

All Listed Sponsors

collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

Spiderwort Biotechnologies Inc.

INDUSTRY

NCT06930209 - Histological Analysis of CelluJuve® Injections in the Brachium | Biotech Hunter | Biotech Hunter